ADT	androgen deprivation therapy
AKT	protein kinase B
AMPK	5′ AMP-activated protein kinase
ANXA7	Annexin A7
AR	androgen receptor
ATP	adenosine triphosphate
BAD	Bcl-2 associated death
C-KβBA	3-Cinnamoyl-11-keto-β-boswellic acid
CRPC	castration-resistant prostate cancer
CTC	circulating tumor cell
FDA	Food and Drug Administration
FGF23	fibroblast growth factor 23
GnRH	gonadotropin-releasing hormone
GOLM1	Golgi membrane protein 1
GTP	guanosine triphosphate
HIF-1	hypoxia-inducible factor-1
HK2	hexokinase 2
IGF	insulin growth factor
MCP-1	monocyte chemoattractant protein-1
mCRPC	metastatic CRPC
mLST8	mammalian lethal with sec-13
mTOR	mammalian target of rapamycin
NCCN	National Comprehensive Cancer Network
NF-κB	nuclear factor-κB
OS	overall survival
P70S6K	P70 S6 kinase
PC	prostate cancer
PFS	progression-free survival
PI3K	phosphatidylinositol 3-kinase
PIKK	phosphatidylinositol-3-kinase-related kinase
PSA	prostate-specific antigen
PTEN	phosphatase and tensin homolog
RAPTOR	regulatory associated protein of mTOR
Rheb	Ras homolog enriched in the brain
TGF-β	transforming growth factor-β
TNF-α	tumor necrosis factor-α
TSC1/TSC2	the tuberous sclerosis complex